Schuessler Tissue Salts Comb 12 General Tonic (Calcarea Fluorica,Calcarea Phosphorica,Calcarea Sulphurica,Ferrum Phosphoricum,Kali Phosphoricum,Kali Muriaticum,Kali Sulphuricum,Magnesia Phosphorica,Natrum Muriaticum,Natrum Phosphoricum,Natrum Sulphuricum,Silicea)
**Product type:** Human Otc Drug
**Active ingredient:** CALCIUM FLUORIDE; CALCIUM SULFATE DIHYDRATE; DIBASIC POTASSIUM PHOSPHATE; FERROUS PHOSPHATE; MAGNESIUM PHOSPHATE, DIBASIC; POTASSIUM CHLORIDE; POTASSIUM SULFATE; SILICON DIOXIDE; SODIUM CHLORIDE; SODIUM PHOSPHATE, DIBASIC, ANHYDROUS; SODIUM SULFATE ANHYDROUS; TRIBASIC CALCIUM PHOSPHATE
**Strength:** 6; 6; 6; 6; 6; 6; 6; 6; 6; 6; 6; 6 [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1
**Dosage form:** Tablet, Chewable
**Route:** Oral
**Labeler:** Martin & Pleasance Pty Ltd
**Marketing category:** UNAPPROVED HOMEOPATHIC
**Pharmacologic class:** Blood Coagulation Factor [EPC], Calcium [CS], Cations, Divalent [CS], Increased Coagulation Factor Activity [PE], Increased Large Intestinal Motility [PE], Increased Large Intestinal Motility [PE], Increased Large Intestinal Motility [PE], Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Osmotic Activity [MoA], Osmotic Activity [MoA], Osmotic Activity [MoA], Osmotic Activity [MoA], Osmotic Laxative [EPC], Osmotic Laxative [EPC], Osmotic Laxative [EPC], Osmotic Laxative [EPC], Phosphate Binder [EPC], Phosphate Chelating Activity [MoA], Potassium Compounds [CS], Potassium Compounds [CS], Potassium Compounds [CS], Potassium Salt [EPC], Potassium Salt [EPC], Potassium Salt [EPC]
/api/v1/systems/ndc_fda/nodes/84999-029Hierarchy Explorer
Cross-system equivalences0
No cross-system equivalences mapped for this node.